Angiotensin and insulin resistance: conspiracy theory (Q35087002)

6 August 2017

1 reference

title

Angiotensin and insulin resistance: conspiracy theory (English)

1 reference

6 August 2017

1 reference

1 reference

Raymond R Townsend

1

1 reference

6 August 2017

1 April 2003

1 reference

Current Hypertension Reports

6 August 2017

1 reference

6 August 2017

5

1 reference

6 August 2017

2

1 reference

6 August 2017

110-116

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-003-0066-1

6 August 2017

0 references

cites work

Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-003-0066-1

Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-003-0066-1

Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.

21 January 2018

1 reference

12 December 2020

PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION

1 reference

12 December 2020

Effects of enalapril on the vascular wall in an experimental model of syndrome X.

1 reference

12 December 2020

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

1 reference

12 December 2020

The effect of Losartan on insulin resistance and beta cell function in chronic hemodialysis patients

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Comparison of haemodynamic effects of equipressor doses of intravenous angiotensin and noradrenaline in man.

1 reference

12 December 2020

PAI-1 in human hypertension: relation to hypertensive groups

1 reference

12 December 2020

Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.

1 reference

12 December 2020

Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women

1 reference

12 December 2020

The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications

1 reference

12 December 2020

The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity

1 reference

12 December 2020

Insulin resistance and vessel endothelial function.

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

Losartan mediated improvement in insulin action is mainly due to an increase in non-oxidative glucose metabolism and blood flow in insulin-resistant hypertensive patients

1 reference

12 December 2020

Insulin Resistance, Hyperinsulinemia, and Coronary Artery Disease: A Complex Metabolic Web

1 reference

12 December 2020

Losartan modifies glomerular hyperfiltration and insulin sensitivity in type 1 diabetes

1 reference

12 December 2020

Insulin resistance syndrome: interaction with coagulation and fibrinolysis

1 reference

12 December 2020

Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism

1 reference

12 December 2020

The role of the renin-angiotensin system in insulin sensitivity in normotensive subjects.

1 reference

12 December 2020

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

Glucose and insulin metabolism in hypertension

1 reference

12 December 2020

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

12 December 2020

Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.

1 reference

12 December 2020

Effects of losartan on insulin sensitivity in hypertensive subjects

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension.

1 reference

12 December 2020

Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men

1 reference

12 December 2020

Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance

1 reference

12 December 2020

Plasma renin activity and insulin sensitivity in normotensive subjects.

1 reference

12 December 2020

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

1 reference

12 December 2020

Insulin resistance in essential hypertension

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

1 reference

12 December 2020

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

1 reference

12 December 2020

Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome.

1 reference

12 December 2020

Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension.

1 reference

12 December 2020

10.1007/S11906-003-0066-1

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12642009